Microsoft and Ginkgo unveil AI discovery platform

Microsoft said on June 2 that its Microsoft Discovery platform is now generally available, moving a year-old research product into broader use for scientific and engineering teams. The company said the platform is designed to build and govern “agentic AI workflows” across research and development, including life sciences work. Ginkgo Bioworks is one of the named partners around the platform, linking Microsoft’s AI and cloud tooling with Ginkgo’s automated biology infrastructure. The core pitch is straightforward. Microsoft is trying to make more of the research process software-driven: gathering prior knowledge, generating hypotheses, coordinating specialized tools, running simulations, and preserving the chain of evidence behind decisions. Ginkgo’s role is to connect that software layer to real lab execution in biotechnology, where experiment design and physical testing are often the slowest parts of the loop. (azure.microsoft.com) ### So what did Microsoft actually launch? Microsoft announced general availability for Microsoft Discovery at Build on June 2, 2026, and also introduced a preview of a local desktop app for researchers and students. The company described Discovery as a platform for scientific and engineering work rather than a general chatbot, with controls for governance, transparency and review. (azure.microsoft.com) Microsoft’s earlier launch description, published at Build 2025, said the system combines specialized AI agents with a graph-based knowledge engine. The company said researchers can use it for “advanced knowledge reasoning,” hypothesis formulation, simulation and iterative learning, all on top of Azure infrastructure. ### Where does Ginkgo fit into this? Ginkgo’s business gives the partnership its laboratory side. (azure.microsoft.com) On its website, Ginkgo says “labwork is the bottleneck for biotechnology” and presents its autonomous lab and cloud lab as ways to let scientists run experimental work through robotic systems rather than manual bench processes. That matters because Microsoft Discovery is strongest on orchestration, reasoning and compute, while Ginkgo is set up to handle biology execution. (azure.microsoft.com) In practice, that means a researcher could use software to narrow a question, design candidate experiments and organize evidence before handing work into an automated lab system built for biotech workflows. That is an inference from the two companies’ published descriptions of their products, not a direct joint quote. (ginkgo.bio) ### Why are companies pushing this kind of platform now? Microsoft said scientific work requires more than “a prompt interface or a single model response.” In its June 2 post, the company said research teams need connections to institutional knowledge, modeling and analysis tools, experimental evidence and formal review processes. Ginkgo has been repositioning around autonomous labs and AI-linked biology services. (azure.microsoft.com) Its investor news page shows a February 2026 launch for Ginkgo Cloud Lab, an April 2026 earnings update that said it was continuing to scale its autonomous lab, and several 2025-26 announcements around AI-enabled drug discovery and lab-in-the-loop workflows. ### What does this change for biotech and healthcare research teams? (azure.microsoft.com) Microsoft’s documents describe Discovery as a way to automate pieces of the research cycle without removing human oversight. The company said the platform is meant to keep “human judgment” at the center of scientific decisions, while using agents to execute research tasks, coordinate tools and work across internal and external knowledge sources. (investors.ginkgobioworks.com) For biotech teams, the practical implication is less about replacing scientists than about compressing handoffs between software analysis and lab work. That increases the value of people who can work across both sides of the system: data, models, cloud infrastructure and experimental design. Microsoft’s platform description and Ginkgo’s autonomous lab pitch both point in that direction, though neither company attached hiring figures to the announcement. (azure.microsoft.com) ### What should readers watch next? Microsoft’s next near-term milestone is adoption of Microsoft Discovery now that the platform is generally available, with the Discovery app still in preview as of June 2. Ginkgo’s next public checkpoints are likely to come through its investor news updates and product announcements tied to its cloud lab and autonomous lab businesses. (azure.microsoft.com)